Log In
Print
BCIQ
Print
Print this Print this
 

HyQ, HyQvia

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionSubcutaneous formulation of IV Gammagard, an IgG antibodies plasma-based therapy, and rHuPH20, a recombinant human PH20 hyaluronidase enzyme
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentRegistration
IndicationImmunodeficiency
Partner

Halozyme Therapeutics Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today